Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy - León-Castillo, A; de Boer, SM; Powell, ME (J Clin Oncol, 2020)